Expression of the Multidrug-Resistance Gene Product in Untreated Human Breast Cancer and its Relationship to Prognostic Markers

References

• Henderson C I, Harris J R, Kinne D W, Hellman S. Cancer of the breast. Cancer principles and practice of oncology, V T Devita, S Hellman, S A. Rosenberg. J.B. Lipincott Co., Philadelphia, PA 1989; 1197–258
   Google Scholar
• Ford J M, Hait W N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990; 42: 15–199
   Web of Science ®Google Scholar
• Harris A L, Hochhauser D. Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 1992; 31: 205–13
   PubMed Web of Science ®Google Scholar
• Salmon S E, Grogan T M, Miller T, Scheper R, Dalton W S. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 1989; 696–701
   PubMedGoogle Scholar
• Keith W N, Stallard S, Brown R. Expression of mdr and gst in human breast tumors: comparison to in vitro chemosensitivity. Br J Cancer 1990; 61: 712–6
   PubMed Web of Science ®Google Scholar
• Dixon A R, Bell J, Ellis I O, Elston C W, Blarney R W. P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy. Br J Cancer 1992; 66: 537–41
   PubMed Web of Science ®Google Scholar
• Auer G U, Caspersson T O, Wallgren A S. DNA content and survival in mammary carcinoma. Anal Quant Histol 1980; 2: 161–5
   PubMedGoogle Scholar
• Kallioniemi O P, Blanco G, Alavaikko M, et al. Tumour DNA ploidy as an independant prognostic factor. Br J Cancer 1987; 56: 637–42
   PubMed Web of Science ®Google Scholar
• Clark G M, McGuire W L. Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 1988; 15: 20–5
   PubMed Web of Science ®Google Scholar
• Fisher B, Redmond C, Fisher E R, Caplan R. Relative worth of estrogen and progesterone receptors and pathologic characteristics of differentiation as indicators of prognosis in node-negative breast cancer patients: Findings from NSABP protocol B-06. J Clin Oncol 1988; 6: 1076–87
   PubMed Web of Science ®Google Scholar
• Nomura Y, Miura S, Koyama H, et al. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. Cancer 1992; 69: 153–64
   PubMed Web of Science ®Google Scholar
• Suguwara I, Kataoka I, Morishita Y, et al. Tissue distribu-tionof P-glycoprotein encoded by a multidrug resistance gene as revealed by a monoclonal antibody, MRK16. Cancer Res 1988; 48: 1926–9
   PubMed Web of Science ®Google Scholar
• Schneider J, Bak M, Efferth Th, Kaufmann M, Mattern J, Volm M. P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 1989; 60: 815–8
   PubMed Web of Science ®Google Scholar
• Wallner J, Depich D, Hopfner M, et al. MDRI gene expression and prognostic factors in primary breast carcinomas. Eur J Cancer 1991; 27: 1352–5
   PubMed Web of Science ®Google Scholar
• Kartner N, Evernden-Porelle D, Bradley G, Ling V. Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature 1989; 316: 820–3
   Google Scholar
• Hamada H, Tsuruo T. Functional role for the 170 to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 1986; 83: 7785–9
   PubMed Web of Science ®Google Scholar
• Vindelöv L L, Christensen I BJ, Nissen N I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323–7
   PubMedGoogle Scholar
• Hidemann W, Schumann J, Andreef M, et al. Convention on nomenclature for DNA cytometry. Cytometry 1984; 5: 445–6
   Google Scholar
• Bloom H JG, Richardson W W. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359–77
   PubMed Web of Science ®Google Scholar
• Burton K. Studies of conditions and mechanism of diphenilamine reaction for colorimetric estimation of deoxiribonucleic acid. Biochem J 1956; 62: 315–23
   PubMed Web of Science ®Google Scholar
• Bergh J, Esscher T, Steinholtz L, Nilsson K, Pahlman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol 1985; 84: 1–7
   PubMed Web of Science ®Google Scholar
• Colton T. Statistics in medicine. Little Brown Co., Boston 1974
   Google Scholar
• Georges E, Bradley G, Garipey J, Ling V. Detection of P-glycoprotein isoforms by gene specific monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 152–6
   PubMed Web of Science ®Google Scholar
• Schinkel A H, Roelofs M EM, Borst P. Characterization of the human MDR3 p-glycoprotein-specific monoclonal antibodies. Cancer Res 1991; 51: 2628–36
   PubMed Web of Science ®Google Scholar
• Wishart G C, Plumb J A, Going J J, et al. P-glycoprotein expression in primary breast cancer detected by immunohistochemistry with two monoclonal antibodies. Br J Cancer 1990; 62: 758–61
   PubMed Web of Science ®Google Scholar
• Verrelle P, Maissonnier F, Fonck Y, et al. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 1991; 83: 111–6
   PubMed Web of Science ®Google Scholar
• Goldstein L J, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116–24
   PubMed Web of Science ®Google Scholar
• Merkel D E, Fuqua S AW, Tandon A K, Hill S M, Buzdar A U, McGuire W L. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol 1989; 7: 1129–36
   PubMed Web of Science ®Google Scholar
• Qin Li Y, Gopal V, Kadam P, Files S, Preisler H. The multiple drug resistance gene, MDR1: Expression at the protein and RNA levels. Med Oncol Tumor Pharmacother 1992; 9: 3–9
   PubMedGoogle Scholar
• Schleifer D, Laurent G, Chittal S, et al. Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers. Br J Cancer 1990; 62: 177–82
   PubMed Web of Science ®Google Scholar
• Thiebaut T, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Immunohistochemical localisation in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localisation in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem 1989; 37: 159–64
   PubMed Web of Science ®Google Scholar
• Finstad C L, Yin B WT, Gordon C M, Federici M G, Welt S, Lloyd K. Some monoclonal antibody reagents (C219 and 15B-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants. J Histochem Cytochem 1991; 39: 1603–10
   PubMed Web of Science ®Google Scholar
• de la Torre M, Hao X-Y, Larsson R, et al. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathine transferases. Anticancer Res 1993; 13: 1425–30
   PubMed Web of Science ®Google Scholar
• Ro J, Sahin A, Ro J Y, Fritsche H, Hortobagyi G, Blick M. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 1990; 21: 787–91
   PubMed Web of Science ®Google Scholar
• Sanfilippo O, Ronchi E, De Marco C, Di Fronzo G, Silvestrini R. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristin. Eur J Cancer 1991; 27: 155–8
   PubMed Web of Science ®Google Scholar